Skip to content
Search

Latest Stories

UK set to step up coronavirus vaccinations: FT

Britain is set to step up coronavirus vaccinations with 500,000 doses a day by next week, the Financial Times reported on Thursday (Jan 14), citing a Scottish government document.

Britain will have secured enough vaccines to inoculate most of the 15 million most vulnerable people that the government is aiming to offer the vaccine by mid-February, the report said.


The document, which was published online by the Scottish government on Wednesday and was later withdrawn, showed that vaccines from Pfizer Inc, AstraZeneca Plc and Moderna Inc are scheduled to arrive in significant quantities in the early summer, the FT said.

The Scottish government expects to receive 309,000 doses from next week, which equates to almost 3.8 million across the UK, according to the FT report.

Prime Minister Boris Johnson had said on Wednesday that Britain is targeting a 24-hour, seven-day-a week Covid-19 vaccination programme as soon as possible.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
It is official: Opella is now a standalone company

Opella launches as an independent company to redefine the future of self-care.

Photo credit: gettyimages

Opella becomes standalone company as Sanofi-CD&R deal closes

Opella has officially become a standalone company, following the completion of Sanofi’s sale of a controlling 50.0% stake to private equity firm Clayton, Dubilier & Rice (CD&R).

Sanofi retains a significant shareholding with a 48.2% stake while Bpifrance holds the remaining 1.8% stake.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less